{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:19:28Z","timestamp":1785842368346,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/bjc.2011.581","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T21:14:46Z","timestamp":1326834886000},"page":"975-981","source":"Crossref","is-referenced-by-count":93,"title":["HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications"],"prefix":"10.1038","volume":"106","author":[{"given":"D C","family":"Rijkaart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"van Kemenade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V M H","family":"Coupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Rozendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A M","family":"Heideman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H M","family":"Verheijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bulk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J F","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J L M","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"BFbjc2011581_CR1","first-page":"292","volume-title":"Obstetrical and Gynaecological Pathology","author":"MC Anderson","year":"1995","unstructured":"Anderson MC (1995) Premalignant and malignant squamous lesions of the cervix. In: Fox H, Wells M (eds). Obstetrical and Gynaecological Pathology, 4th edn. Churchill Livingstone: New York, pp 292\u2013297"},{"key":"BFbjc2011581_CR2","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","volume":"45","author":"M Arbyn","year":"2009","unstructured":"Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A (2009) Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 45: 2640\u20132648","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"BFbjc2011581_CR3","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.vaccine.2006.05.117","volume":"24","author":"M Arbyn","year":"2006","unstructured":"Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J (2006) Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24 (Suppl 3): S78\u2013S89","journal-title":"Vaccine"},{"key":"BFbjc2011581_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/ijc.22677","volume":"121","author":"S Bulk","year":"2007","unstructured":"Bulk S, Bulkmans NW, Berkhof J, Rozendaal L, Boeke AJ, Verheijen RH, Snijders PJ, Meijer CJ (2007) Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months. Int J Cancer 121: 361\u2013367","journal-title":"Int J Cancer"},{"key":"BFbjc2011581_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jcp.2003.011841","volume":"57","author":"S Bulk","year":"2004","unstructured":"Bulk S, van Kemenade FJ, Rozendaal L, Meijer CJ (2004) The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 57: 388\u2013393","journal-title":"J Clin Pathol"},{"key":"BFbjc2011581_CR6","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","volume":"370","author":"NW Bulkmans","year":"2007","unstructured":"Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van GK, Boon ME, Ruitinga W, van BM, Snijders PJ, Meijer CJ (2007) Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370: 1764\u20131772","journal-title":"Lancet"},{"key":"BFbjc2011581_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jspi.2004.01.005","volume":"131","author":"T Cai","year":"2005","unstructured":"Cai T (2005) One-sided confidence intervals in discrete distributions. J Stat Plan Inference 131: 63\u201388","journal-title":"J Stat Plan Inference"},{"key":"BFbjc2011581_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ajog.2007.07.049","volume":"197","author":"PE Castle","year":"2007","unstructured":"Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M (2007) Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol 197: 356","journal-title":"Am J Obstet Gynecol"},{"key":"BFbjc2011581_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/jcp.57.1.68","volume":"57","author":"KS Cuschieri","year":"2004","unstructured":"Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E (2004) Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57: 68\u201372","journal-title":"J Clin Pathol"},{"key":"BFbjc2011581_CR10","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119: 1095\u20131101","journal-title":"Int J Cancer"},{"key":"BFbjc2011581_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1470-2045(09)70177-9","volume":"10","author":"EL Franco","year":"2009","unstructured":"Franco EL (2009) Is the UK ready to embrace HPV testing? Lancet Oncol 10: 643\u2013644","journal-title":"Lancet Oncol"},{"key":"BFbjc2011581_CR12","doi-asserted-by":"crossref","unstructured":"Giorgi-Rossi P, Franceschi S, Ronco G (2011) HPV prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia. Int J Cancer; e-pub ahead of print 25 April 2011; doi: 10.1002\/ijc.26147","DOI":"10.1002\/ijc.26147"},{"key":"BFbjc2011581_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/jnci\/djn019","volume":"100","author":"JD Goldhaber-Fiebert","year":"2008","unstructured":"Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ (2008) Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination. J Natl Cancer Inst 100: 308\u2013320","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2011581_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1159\/000326965","volume":"46","author":"AG Hanselaar","year":"2002","unstructured":"Hanselaar AG (2002) Criteria for organized cervical screening programs. Special emphasis on The Netherlands program. Acta Cytol 46: 619\u2013629","journal-title":"Acta Cytol"},{"key":"BFbjc2011581_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1471-0528.2000.tb13299.x","volume":"107","author":"EH Hopman","year":"2000","unstructured":"Hopman EH, Rozendaal L, Voorhorst FJ, Walboomers JM, Kenemans P, Helmerhorst TJ (2000) High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. BJOG 107: 600\u2013604","journal-title":"BJOG"},{"key":"BFbjc2011581_CR16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.35.3.791-795.1997","volume":"35","author":"MV Jacobs","year":"1997","unstructured":"Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM (1997) A general primer GP5+\/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35: 791\u2013795","journal-title":"J Clin Microbiol"},{"key":"BFbjc2011581_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","volume":"10","author":"HC Kitchener","year":"2009","unstructured":"Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R, Desai M, Mather J, Bailey A, Turner A, Moss S, Peto J (2009) HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 10: 672\u2013682","journal-title":"Lancet Oncol"},{"key":"BFbjc2011581_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/sj.bjc.6602799","volume":"93","author":"L Kotaniemi-Talonen","year":"2005","unstructured":"Kotaniemi-Talonen L, Nieminen P, Anttila A, Hakama M (2005) Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer 93: 862\u2013867","journal-title":"Br J Cancer"},{"key":"BFbjc2011581_CR19","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.288.14.1749","volume":"288","author":"SL Kulasingam","year":"2002","unstructured":"Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA (2002) Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 288: 1749\u20131757","journal-title":"JAMA"},{"key":"BFbjc2011581_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","volume":"367","author":"M Kyrgiou","year":"2006","unstructured":"Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E (2006) Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367: 489\u2013498","journal-title":"Lancet"},{"key":"BFbjc2011581_CR21","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/jnci\/djp367","volume":"101","author":"M Leinonen","year":"2009","unstructured":"Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A (2009) Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 101: 1612\u20131623","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2011581_CR22","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"MH Mayrand","year":"2007","unstructured":"Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F, Franco EL (2007) Human papillomavirus DNA vs Papanicolaou screening tests for cervical cancer. N Engl J Med 357: 1579\u20131588","journal-title":"N Engl J Med"},{"key":"BFbjc2011581_CR23","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/ijc.20839","volume":"114","author":"T Molden","year":"2005","unstructured":"Molden T, Nygard JF, Kraus I, Karlsen F, Nygard M, Skare GB, Skomedal H, Thoresen SO, Hagmar B (2005) Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL pap smear. Int J Cancer 114: 973\u2013976","journal-title":"Int J Cancer"},{"key":"BFbjc2011581_CR24","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa073204","volume":"357","author":"P Naucler","year":"2007","unstructured":"Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Radberg T, Strander B, Forslund O, Hansson BG, Rylander E, Dillner J (2007) Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357: 1589\u20131597","journal-title":"N Engl J Med"},{"key":"BFbjc2011581_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/path.2598","volume":"219","author":"RM Overmeer","year":"2009","unstructured":"Overmeer RM, Henken FE, Bierkens M, Wilting SM, Timmerman I, Meijer CJ, Snijders PJ, Steenbergen RD (2009) Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis. J Pathol 219: 327\u2013336","journal-title":"J Pathol"},{"key":"BFbjc2011581_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/path.2367","volume":"215","author":"RM Overmeer","year":"2008","unstructured":"Overmeer RM, Henken FE, Snijders PJ, Claassen-Kramer D, Berkhof J, Helmerhorst TJ, Heideman DA, Wilting SM, Murakami Y, Ito A, Meijer CJ, Steenbergen RD (2008) Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol 215: 388\u2013397","journal-title":"J Pathol"},{"key":"BFbjc2011581_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ajog.2004.02.065","volume":"191","author":"RG Pretorius","year":"2004","unstructured":"Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, Qiao YL (2004) Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 191: 430\u2013434","journal-title":"Am J Obstet Gynecol"},{"key":"BFbjc2011581_CR28","unstructured":"Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ (2011a) Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: results over two screening rounds of the POBASCAM trial. Lancet Oncol; e-pub ahead of print 14 December 2011"},{"key":"BFbjc2011581_CR29","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ijc.24891","volume":"126","author":"DC Rijkaart","year":"2010","unstructured":"Rijkaart DC, Berkhof J, van Kemenade FJ, Rozendaal L, Verheijen RH, Bulk S, Herreilers ME, Verweij WM, Snijders PJ, Meijer CJ (2010) Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study). Int J Cancer 126: 2175\u20132181","journal-title":"Int J Cancer"},{"key":"BFbjc2011581_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/ijc.26056","volume":"130","author":"DC Rijkaart","year":"2011","unstructured":"Rijkaart DC, Berkhof J, van Kemenade FJ, Coupe VM, Hesselink AT, Rozendaal L, Heideman DA, Verheijen RH, Bulk S, Verweij WM, Snijders PJ, Meijer CJ (2011b) Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer 130: 602\u2013610","journal-title":"Int J Cancer"},{"key":"BFbjc2011581_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jnci\/djq001","volume":"102","author":"AC Rodriguez","year":"2010","unstructured":"Rodriguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD (2010) Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2\/3: critical role of duration of infection. J Natl Cancer Inst 102: 315\u2013324","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2011581_CR32","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jnci\/djn065","volume":"100","author":"G Ronco","year":"2008","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, Del MA, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N (2008) Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 100: 492\u2013501","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2011581_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","volume":"11","author":"G Ronco","year":"2010","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Palma PD, Del MA, Ghiringhello B, Girlando S, Gillio-Tos A, De ML, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11: 249\u2013257","journal-title":"Lancet Oncol"},{"key":"BFbjc2011581_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","volume":"7","author":"G Ronco","year":"2006","unstructured":"Ronco G, Giorgi-Rossi P, Carozzi F, Dalla PP, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J (2006a) Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 7: 547\u2013555","journal-title":"Lancet Oncol"},{"key":"BFbjc2011581_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jnci\/djj209","volume":"98","author":"G Ronco","year":"2006","unstructured":"Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla PP, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J (2006b) Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 98: 765\u2013774","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2011581_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/jnci\/94.3.193","volume":"94","author":"ME van den Akker-van Marle","year":"2002","unstructured":"van den Akker-van Marle ME, van Ballegooijen M, van Oortmarssen GJ, Boer R, Habbema JD (2002) Cost-effectiveness of cervical cancer screening: comparison of screening policies. J Natl Cancer Inst 94: 193\u2013204","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2011581_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1128\/JCM.40.3.779-787.2002","volume":"40","author":"AJ van den Brule","year":"2002","unstructured":"van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+\/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40: 779\u2013787","journal-title":"J Clin Microbiol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2011581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011581","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T23:03:01Z","timestamp":1713394981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2011581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,17]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["BFbjc2011581"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2011.581","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,17]]}}}